C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT

Nick A. Francis*, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Bernadette Sewell, Rhiannon Phillips, Helen Stanton, Nigel Kirby, Mandy Wootton, Emma Thomas-Jones, Kerenza Hood, Carl Llor, Jochen Cols, Hasse Melbye, Gurudutt Naik, Micaela Gal, Deborah Fitzsimmons, Mohammed Fasihul Alam, Evgenia RigaAnn Cochrane, Christopher C. Butle

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1-+
Number of pages110
JournalHealth Technology Assessment
Volume24
Issue number15
DOIs
Publication statusPublished - Mar 2020

Keywords

  • RESPIRATORY-TRACT INFECTIONS
  • MULTIPLE END-POINTS
  • COST-EFFECTIVENESS
  • STREPTOCOCCUS-PNEUMONIAE
  • AIRWAY INFLAMMATION
  • CLINICIAN VIEWS
  • DATA SATURATION
  • COPD
  • RESISTANCE
  • THERAPY

Cite this

Francis, N. A., Gillespie, D., White, P., Bates, J., Lowe, R., Sewell, B., Phillips, R., Stanton, H., Kirby, N., Wootton, M., Thomas-Jones, E., Hood, K., Llor, C., Cols, J., Melbye, H., Naik, G., Gal, M., Fitzsimmons, D., Alam, M. F., ... Butle, C. C. (2020). C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technology Assessment, 24(15), 1-+. https://doi.org/10.3310/hta24150